Baroda BNP Paribas Health and Wellness Fund Regular Growth
EquitySector - Healthcare
9.43
-0.02(-0.24%)
NAV as on 09 Dec, 2025
CAGR
-5.47%
- AUM (Crs.)621.16
- Expense Ratio2.28 %
- Sharpe Ratio / Category Average- / 0.94
- Standard Deviation / Category Average- / 16.00
- Beta / Category Average- / 0.96
- Portfolio Turnover / Category Average- / 56.14
- Top 5 Stocks Wt.35.33
- Top 10 Stocks Wt.57.92
- Top 3 Sectors Wt.95.53
- Investment StyleLarge Growth
- Morningstar Rating
Portfolio
Asset Allocation
Weightage by Market Cap
Concentration
- No. of Stocksundefined
- Avg. Market Capundefined
- Top 10 Stocksundefined%
- Top 5 Stocksundefined%
- Top 3 Sectorsundefined%
View Holdings
Fundamentals
| Measures | Fund | Category Average |
|---|
Risk Metrics
Peers
1Y3Y5Y10Y
| Mutual Fund | AUM (cr.) | 3YReturns |
|---|
Holdings
Stocks
Sector
About
- Fund Manager(s)Check HistorySanjay Chawla
- Launch Date27 Jun, 2025
- BenchmarkS&P BSE 500
Objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Riskometer
More Funds From
| Fund Name | Morningstar Rating | AUM (cr.) | 1Y Returns | 3Y Returns | 5Y Returns |
|---|